Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT02163213
To evaluate the safety and effectiveness of oral nutritional therapy Serum-Derived Bovine Immunoglobulin (SBI) on nutritional status, epithelial barrier function, and mucosal expression of pivotal genes including tight junction, secretory mechanisms, tissue repair proteins and chemokines in subjects with IBS-D.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
This is an open label study evaluating the impact of SBI 5.0 g twice daily on
Plasma, duodenal and stool samples will be collected. Fifteen eligible subjects will be enrolled to receive SBI for 8 weeks (SBI 5.0g BID for 8 weeks).
Intestinal permeability will be measured in vivo by two sugar urine excretion(s) after oral ingestion.
Biopsies from the distal second or third portion of the duodenum will be obtained endoscopically, to measure mRNA expression of tight junction proteins and markers of immune function,
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g bid on Nutritional Status and intestinal functions in Subjects with IBS-D
Time frame: 10 weeks
The primary endpoints for the study are change from baseline in mucosal expression of tight junction proteins (ZO-1, occludin, claudin)
Time frame: 10 weeks
The secondary endpoints for the study is change from baseline in amino acid metabolism
Time frame: 10 weeks
Exploratory endpoints: Duodenal biopsy microbiome
Mayo Clinic
Other
An Open-Label Study Evaluating the Impact of Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Twice Daily on Nutritional Status in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03977155
Colonic Diseases, Colonic Diseases, Functional
Anniston, Alabama, United States
View Trial DetailsNCT02612649
Colonic Diseases, Colonic Diseases, Functional
Numakunai, Iwate, Japan
View Trial DetailsNCT01414244
Colonic Diseases, Colonic Diseases, Functional
New Orleans, Louisiana, United States
View Trial DetailsNCT07000383
Colonic Diseases, Colonic Diseases, Functional
Ho Chi Minh City, District 5, Vietnam
View Trial Details